| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.008 |